Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-02 @ 6:43 PM
Study NCT ID:
NCT03684694
Status:
TERMINATED
Last Update Posted:
2024-02-06
First Post:
2018-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma
Sponsor:
ADC Therapeutics S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-11
First Submit QC Date:
None
Study First Post Date:
2018-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-11-21
Results First Submit QC Date:
None
Results First Post Date:
2024-02-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-10
Last Update Post Date:
2024-02-06
Last Update Post Date Type:
ACTUAL